Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments BayStreet.ca - Fri May 17, 10:48AM CDT

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
RHHBY : 32.8100 (+0.49%)
MRUS : 43.91 (-2.47%)
MGNX : 4.36 (-14.75%)
IMRX : 1.4700 (-4.55%)
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders Newswire.ca - Thu May 16, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection Newswire.ca - Wed May 15, 10:14AM CDT

/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...

ONCY : 1.1100 (-1.77%)
CADL : 11.50 (-9.45%)
ABVC : 1.0700 (+0.94%)
CTMX : 1.8900 (-5.50%)
AMGN : 312.47 (-0.71%)
ONC.TO : 1.51 (-2.58%)
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer BayStreet.ca - Wed May 15, 8:50AM CDT

USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can accurately detect early-stage pancreatic cancer with...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
CADL : 11.50 (-9.45%)
ABVC : 1.0700 (+0.94%)
CTMX : 1.8900 (-5.50%)
AMGN : 312.47 (-0.71%)
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial Newswire.ca - Wed May 15, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights Newswire.ca - Thu May 9, 3:01PM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 FinancialNewsMedia - Thu May 9, 11:15AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
ZLAB : 19.40 (-2.66%)
NTBL : 1.0200 (-1.92%)
CRDF : 3.63 (-2.94%)
JNJ : 154.64 (+0.23%)
Oncolytics Biotech® Receives Regulatory Clearance to Evaluate Pelareorep in Combination with Modified FOLFIRINOX +/- an anti-PD-L1 Inhibitor in Pancreatic Cancer FinancialNewsMedia - Thu May 9, 9:56AM CDT

US$5 million PanCAN grant provides important support for the fifth cohort of the GOBLET study   Study of modified FOLFIRINOX/pelareorep/atezolizumab (Tecentriq ® ) combination expands existing pancreatic...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb Newswire.ca - Thu May 9, 9:22AM CDT

/CNW/ -- In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding...

ONCY : 1.1100 (-1.77%)
CADL : 11.50 (-9.45%)
AZN : 76.90 (-0.18%)
HALO : 44.71 (-1.50%)
JANX : 47.10 (-0.86%)
ONC.TO : 1.51 (-2.58%)
Rising Cancer Rates Drive Biotech Advancements Despite Political Hurdles BayStreet.ca - Thu May 9, 9:13AM CDT

USA News Group – In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden’s “Cancer...

ONCY : 1.1100 (-1.77%)
ONC.TO : 1.51 (-2.58%)
CADL : 11.50 (-9.45%)
AZN : 76.90 (-0.18%)
HALO : 44.71 (-1.50%)
JANX : 47.10 (-0.86%)

Barchart Exclusives

NVDA Earnings, Fed Speakers and Other Key Things to Watch This Week Barchart - Sun May 19, 2:00PM CDT
There was some wild volatility last week as PPI came in hotter than expected and CPI came in just under expectations on the monthly basis. This small decrease in the inflation rate was enough for Fed heads to start talking about rate cuts again the next day. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot